Current neoadjuvant strategies in rectal cancer

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Rectal cancer treatment has evolved over 30 years.
• Recent advances in neoadjuvant therapy have transformed patient management.
• Current neoadjuvant strategies are critical for improving outcomes.

Purpose of the Study:

• To review current evidence-based neoadjuvant strategies for rectal cancer.
• To focus on treatments for locally advanced and metastatic rectal disease.
• To identify and discuss unresolved issues in rectal cancer management.

Main Methods:

• Literature review of contemporary evidence-based neoadjuvant strategies.
• Analysis of chemotherapy and radiation protocols.
• Synthesis of data on locally advanced and metastatic rectal cancer.

Main Results:

• Neoadjuvant therapies represent a significant shift in rectal cancer management.
• Current strategies are highly effective for locally advanced disease.
• Evidence for neoadjuvant treatment in metastatic rectal cancer is evolving.

Conclusions:

• Neoadjuvant chemotherapy and radiation are revolutionizing rectal cancer care.
• Evidence-based strategies are key for optimizing treatment.
• Further research is needed to address remaining challenges in rectal cancer management.